Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Is nuclear war a threat?]

I Melezínek, Z Dienstbier

    Casopis Lekaru Ceskych
    |March 31, 1989
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2010
    Same author

    Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis.

    Neoplasma·2009
    Same author

    [Results of the monitoring the group of patients treated for the Hodgkin disease in the period of 1971 to 1996. Part 2: fertility after therapy].

    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2008
    Same author

    [Results of the monitoring the group of patients treated for the Hodgkin disease in the period of 1971 to 1996. Part 1: long-time survival in dependence of the clinical stage of the disease].

    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2008
    Same author

    [Clinical study of Hodgkin's disease after 25 years].

    Casopis lekaru ceskych·2004
    Same author

    The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study.

    World journal of urology·2003